Abstract
Diabetes Mellitus (DM) has become one of the biggest healthcare challenges of the twenty-first century and it has become one of the major causes of morbidity and mortality across the world. According to the International Diabetic Federation, 425 million had diabetes in the year 2016 and by the year 2045, the number will escalate to 629 million [1]. One of the most common complications of diabetes is Diabetic Neuropathy. According to the American Diabetic Association diabetic neuropathy is “the presence of symptoms and/or signs of peripheral nerve dysfunction in people with diabetes after exclusion of other causes” ‘[2]. The prevalence of diabetic peripheral neuropathy ranges from 16% to 66% [3, 4]. While the incidence of amputation in diabetic patients is 10–20 times greater than in non-diabetic patients [5]. Diabetes Mellitus (DM) has become one of the major causes of morbidity and mortality across the world. Many factors were implicated in the development of Charcot foot such as soft tissue abnormality, abnormal mobility, diabetic peripheral neuropathy, abnormal plantar pressure, and altered gait pattern. A multitude of mechanisms for pathogenesis has been proposed like 1). lack of vaso-regulation resulting in a high flow state and opening of arteriovenous shunting due to underlying autonomic neuropathy, 2). Autonomic neuropathy contributes to local osteopenia by increasing the local blood flow, 3). Pain impairment in Charcot’s foot is associated with repeated injury, resulting in persistent proinflammatory conditions, contributing to chronic local osteolysis, 4). Binding of AGEs to their receptor (RAGE) prevents the differentiation of human mesenchymal stem cells. They induce apoptosis of osteoblast through the RANKL / NF-kβ pathway.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
IDF atlas (2017). Available from: http://www.idf.org/e-library/epidemiology-research/diabetes-atlas.html
American Diabetes Association (2007) Standards of medical care in diabetes—2007 [Position statement]. Diabetes Care 30:S4–S41
Boulton AJ, Vileikyte L, RagnarsonTennvall G et al (2005) The global burden of diabetic foot disease. Lancet 366:1719–1724. https://doi.org/10.1016/S0140-6736(05)67698-2
Boulton AJM, Armstrong DG, Albert SF et al (2008) Comprehensive foot examination and risk assessment. Diabetes Care 31:1679–1685. https://doi.org/10.2337/dc08-9021
Moxey PW, Gogalniceanu P, Hinchliffe RJ et al (2011) Lower extremity amputations – a review of global variability in incidence. Diabet Med 28(10):1144–1153. https://doi.org/10.1111/j.1464-5491.2011.03279.x
van Deursen R (2004) Mechanical loading and off-loading of the plantar surface of the diabetic foot. Clin Infect Dis 39:S87–S91
Cavanagh PR, Rodgers MM, Iiboshi A (1987) Pressure distribution under symptom-free feet during barefoot standing. Foot Ankle 5:262–276
Hotfiel T, Carl HD, Wendler F, Jendrissek A, Heiß R, Swoboda B (2017) Plantar pressures increase with raising body weight: a standardised approach with paired sample using neutral shoes. J Back Musculoskelet Rehabil 30(3):583–589
Martinez-Nova A, Huerta JP, Sánchez-Rodriguez R (2008) Cadence, age, and weight as determinants of forefoot plantar pressures using the biofoot in-shoe system. J Am Podiatr Med Assoc 98(4):302–310
Rao S, Saltzman C, Yack HJ (2006) Ankle ROM and stiffness measured at rest and during gait in individuals with and without diabetic sensory neuropathy. Gait Posture 24(3):295–301
Blanc Y, Balmer C, Landis T, Vingerhoets F (1999) Temporal parameters and patterns of the foot roll over during walking: normative data for healthy adults. Gait Posture 10:97–108
Mueller MJ, Diamond JE, Delitto A, Sinacore DR (1989) Insensitivity, limited joint mobility, and plantar ulcers in patients with diabetes mellitus. Phys Ther 69:453–459
Armstrong DG, Lavery LA (1998) Plantar pressures are higher in diabetic patients following partial foot amputation. Ostomy Wound Manage 44:30–32. 34, 36
Stokes IA, Faris IB, Hutton WC (1975) The neuropathic ulcer and loads on the foot in diabetic patients. Acta Orthop Scand 46:839–847
Barn R, Waaijman R, Nollet F, Woodburn J, Bus SA (2015) Predictors of barefoot plantar pressure during walking in patients with diabetes, peripheral neuropathy and a history of ulceration. PLoS One 10:e0117443
Ledoux WR, Shofer JB, Smith DG, Sullivan K, Hayes SG, Assal M, Reiber GE (2005) Relationship between foot type, foot deformity, and ulcer occurrence in the high-risk diabetic foot. J Rehabil Res Dev 42:665–672
Yavuz M (2014) Plantar shear stress distributions in diabetic patients with and without neuropathy. Clin Biomech (Bristol, Avon) 29:223–229
Lavery LA, Armstrong DG, Wunderlich RP, Tredwell J, Boulton AJM (2003) Predictive value of foot pressure assessment as part of a population-based diabetes disease management program. Diabetes Care 26:1069–1073
Barrett JP, Mooney V (1973) Neuropathy and diabetic pressure lesions. Orthop Clin North Am 4:43–47
Ctercteko GC, Dhanendran M, Hutton WC, Le Quesne LP (1981) Vertical forces acting on the feet of diabetic patients with neuropathic ulceration. Br J Surg 68:608–614
Root ML, Weed JH, Sgarlato TE, Bluth DR (1966) Axis of motion of the sub-talar joint. Am Pod Ass 56:149–155
Lnman VT (1976) The sub-talar joint. In: Lnman VT (ed) The joints of the ankle. Williams and Wilkins, Baltimore, pp 35–43
Delbridge L, Perry P, Marr S, Arnold N, Yue DK, Turtle JR, Reeve TS (1988) Limited joint mobility in the diabetic foot: relationship to neuropathic ulceration. Diabet Med 5:333–337
Delbridge L, Ctercteko G, Fowler C, Reeve TS, LeQuesne LP (1985) The aetiology of neuropathic ulceration in the diabetic foot. Brit Surg 75:1–6
Gefen A, Megido-Ravid M, Azariah M, Itzchak Y, Arcan M (2001) Integration of plantar soft tissue stiffness measurements in routine MRI of the diabetic foot. Clin Biomech (Bristol, Avon) 16:921–925
Abouaesha F, van Schie CH, Griffths GD, Young RJ, Boulton AJ (2001) Plantar tissue thickness is related to peak plantar pressure in the high-risk diabetic foot. Diabetes Care 24:1270–1274
Murray HJ, Young MJ, Hollis S, Boulton AJ (1996) The association between callus formation, high pressures, and neuropathy in diabetic foot ulceration. Diabet Med 13:979–982
van Deursen RW, Sanchez MM, Derr JA, Becker MB, Ulbrecht JS, Cavanagh PR (2001) Vibration perception threshold testing in patients with diabetic neuropathy: ceiling effects and reliability. Diabet Med 18:469–475
Brand PW (1983) The diabetic foot. In: Ellenberg M, Rifkin H (eds) Diabetes mellitus: theory and practice, 3rd edn. Medical Examination Publishing, New York, pp 829–849
Zhu H, Wertsch JJ, Harris GF, Lofisgaarden JD, Price MB (1991) Foot pressure distribution during walking and shuffling. Arch Phys Med Rehabll 72:390–397
Fernando ME, Crowther RG, Pappas E, Lazzarini PA, Cunningham M, Sangla KS, Buttner P, Golledge J (2014) Plantar pressure in diabetic peripheral neuropathy patients with active foot ulceration, previous ulceration and no history of ulceration: a meta-analysis of observational studies. PLoS One 9:e99050
Rosenbaum D, Hautmann S, Gold M, Claes L (1994) Effects of walking speed on plantar pressure patterns and hindfoot angular motion. Gait Posture 2:191–197
Fernando M, Crowther R, Lazzarini P, Sangla K, Cunningham M, Buttner P, Golledge J (2013) Biomechanical characteristics of peripheral diabetic neuropathy: a systematic review and meta-analysis of findings from the gait cycle, muscle activity and dynamic barefoot plantar pressure. Clin Biomech (Bristol, Avon) 28(8):831–845
Fernando ME, Crowther RG, Pappas E et al (2014) Plantar pressure in diabetic peripheral neuropathy patients with active foot ulceration, previous ulceration and no history of ulceration: a meta-analysis of observational studies. PLoS One 9(6):e99050
Couppé C, Svensson RB, Kongsgaard M et al (2016) Human Achilles tendon glycation and function in diabetes. J Appl Physiol 120(2):130–137
Cavanagh PR, Sims DS Jr, Sanders LJ (1991) Body mass is a poor predictor of peak plantar pressure in diabetic men. Diabetes Care 14:750–755
Caputo GM, Cavanagh PR, Ulbrecht JS et al (1994) Assessment and management of foot disease in patients with diabetes. N Engl J Med 331:854–860
Charcot JM (1868) Sur quelques arthropathies qui paraiise d’ependre d’ une l’esion du cerveau ou de la mouelle épini’ere. Arch Physiol Norm Pathol 1:161–178
Jordan WR (1936) Neuritic manifestations in diabetes mellitus. Arch Intern Med 57:307–366
Rajbhandari SM, Jenkins RC, Davies C, Tesfaye S (2002) Charcot neuroarthropathy in diabetes mellitus. Diabetologia 45:1085–1096
Salini D, Harish K, Minnie P et al (2018) Prevalence of Charcot arthropathy in type 2 diabetes patients aged over 50 years with severe peripheral neuropathy: a retrospective study in a tertiary care South Indian Hospital. Indian J Endocrinol Metab 22:107–111
Ramanujam CL, Zgonis T (2017) The diabetic Charcot foot from 1936 to 2016: eighty years later and still growing. Clin Podiatr Med Surg 34:1–8
Jeffcoate WJ, Game F, Cavanagh PR (2005) The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes. Lancet 366:2058–2061
Boyce BF, Xing L (2008) Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys 473:139–146
Larson SA, Burns PR (2012) The pathogenesis of Charcot neuroarthropathy: current concepts. Diabet Foot Ankle 3
Katayama Y, Akatsu T, Yamamoto M et al (1996) Role of nonenzymatic glycosylation of type I collagen in diabetic osteopenia. J Bone Miner Res 11:931–937
Jeffcoate WJ, Game FL (2010) New theories on the causes of the Charcot foot in diabetes. In: Frykberg RG (ed) The diabetic Charcot foot: principles and management. Data Trace Publishing Company, Brooklandville, MD, pp 29–44
Eichenholtz SN (1966) Charcot joints. Charles C. Thomas, Springfield, IL
Cofield RH, Morrison MJ, Beabout JW (1983) Diabetic neuroarthropathy in the foot: patient characteristics and patterns of radiographic change. Foot Ankle 4:15–22
Morrison WB, Ledermann HP (2002) Work-up of the diabetic foot. Radiol Clin North Am 40:1171–1192
Caputo GM, Ulbrecht J, Cavanagh PR et al (1998) The Charcot foot in diabetes: six key points. Am Fam Physician 57:2705–2710
Rogers LC, Frykberg RG, Armstrong G, Boulton AJM, Edmonds M, Ha Van G et al (2011) The Charcot foot in diabetes. Diabetes Care 34(9):2123–2129
Keidar Z, Militianu D, Melamed E et al (2005) The diabetic foot: initial experience with 18F-FDG PET/CT. J Nucl Med 46:444–449
Armstrong DG, Lavery LA (1997) Monitoring healing of acute Charcot’s arthropathy with infrared dermal thermometry. J Rehabil Res Dev 34:317–321
Durgia H, Sahoo J, Kamlanathan S et al (2018) Role of bisphosphonates in the management of acute Charcot foot. World J Diabetes 9(7):115–126
Dhawan V, Spratt KF, Pinzur MS et al (2005) Reliability of AOFAS diabetic foot questionnaire in Charcot arthropathy: stability, internal consistency, and measurable difference. Foot Ankle Int 26:717–731
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Faraz, A., Ashraf, H., Khalid, S., Fatima, R. (2021). Foot Pressure Abnormalities, Radiographic, and Charcot Changes in the Diabetic Foot. In: Zubair, M., Ahmad, J., Malik, A., Talluri, M.R. (eds) Diabetic Foot Ulcer. Springer, Singapore. https://doi.org/10.1007/978-981-15-7639-3_7
Download citation
DOI: https://doi.org/10.1007/978-981-15-7639-3_7
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-7638-6
Online ISBN: 978-981-15-7639-3
eBook Packages: MedicineMedicine (R0)